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Abstract
Background: The National Nutrition Research Roadmap has called for support of greater
collaborative, interdisciplinary research for multiple areas of nutrition research. However, a
substantial reduction in federal funding makes responding to these calls challenging.
Objectives: The objectives of this study were to examine temporal trends in research funding and
to discuss the potential consequences of these trends.
Methods: We searched the NIH RePORTER database to identify NIH research grants and
USASpending to identify National Science Foundation and USDA research grants awarded from
1992 to 2015. We focused on those that pertained to vitamin research. For the years 2000 to
2015, we examined funding trends for different vitamins, including vitamins A, B (one-carbon
B-vitamins were considered separately from other B-vitamins), C, D, E, and K.
Results: From 1992 to 2015, total federal research spending increased from ;$14 to $45 billion
(2016 US dollars). Although vitamin research spending increased from ;$89 to $95 million, the
proportion of grants awarded for vitamin research declined by more than two-thirds, from 0.65%
in 1992 to 0.2% in 2015. Federal agencies awarded 6035 vitamin research grants over the time
period, with vitamin A associated with the most research projects per year on average (n = 115)
and vitamin K the fewest (n = 8). Vitamin D research projects were associated with the greatest
average yearly project value ($34.8 million).
Conclusions: Vitamin research has faced a disproportionate decline in research funding from 1992
to 2015. Insufﬁcient federal research funding streams risk stalling progress in vitamin research and
leaving important advancements unrealized. Curr Dev Nutr 2017;1:e000430.
Introduction
Federal funding continues to be the principal source of ﬁnancial support for academic re-
search centers globally and is the backbone of biomedical research in the United States
(1). However, federal funding agencies have faced substantial budget reductions in recent de-
cades. Since the early 1990s, the share of the federal budget allocated to research funding has
declined from.5% of the federal budget to;3.8% (2). This sustained reduction in the pro-
portion of the federal budget allocated to research funding threatens the sustainability of
biomedical research and ultimately will slow the pace of innovation and scientiﬁc progress.
Although it is expected that federal research funding should track federally mandated
research priorities, it is unclear how the overall reductions in federal research funding
have varied across research disciplines. During an era in which the general public has
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unprecedented interest in nutrition guidance to improve quality of
life and reduce the risk of speciﬁc chronic diseases, advancements
in chronic disease prevention in the United States, including pro-
motion of healthy eating patterns, have not kept pace with similar
advancements in other aﬄuent economies (3). Federal funding for
chronic disease prevention currently focuses on the following: 1)
prevention across the life cycle, 2) practical solutions to targeted
interventions, and 3) personalized solutions. One of the strategic
priorities of the NIH is to accelerate the development of precise,
individualized approaches to disease prevention (1). Similarly,
the National Nutrition Research Roadmap 2016–2021, recently an-
nounced by the Interagency Committee on Human Nutrition Re-
search, includes a call for the support of greater collaborative,
interdisciplinary research for multiple areas of nutrition research,
such as understanding the eﬀects of individual variability on bio-
logical measures related to the epigenome, microbiome, metabo-
lome, and proteome (4). However, the feasibility of responding
to these federally issued calls for more interdisciplinary nutrition
research concurrent to a period of perceived declines in federal
funding is unclear.
Funding for nutrition research spans multiple federal agencies,
but there is no universal tracking system of project funding across
federal agencies in the United States. To address this challenging
question, we chose to focus our study on trends in federal funding
for vitamin research, which can span from fundamental science to
the application of omics technology to understanding the individ-
ual response of vitamin precursors and metabolites in prevention
of speciﬁc chronic disease processes. Our focus on vitamins com-
plements the 2015 Dietary Guidelines for Americans Scientiﬁc
Report, which identiﬁed multiple vitamins as nutrients that are
underconsumed in the United States, relative to recommended in-
takes set by the Institute ofMedicine (5). We had 2 study objectives:
1) to compare how federal funding for vitamin research has changed
over time relative to all federal research funding (2000–2015) and 2)
to examine how research funding for speciﬁc vitamin types has
changed over time. The outcome of this analysis will provide insight
into gaps between research funding and research priorities in vita-
min research, and identify shifts in funding over time.
Methods
Data sources
We included research grants from the NIH, the National Science
Foundation (NSF), and the USDA. For the USDA, we included
only grants awarded by the Agricultural Research Services; the Co-
operative State Research, Education, and Extension Service; and the
National Institute of Food and Agriculture because we considered
these divisions to be those most pertinent to vitamin funding.
We used NIH RePORTER to identify research grants awarded
by the NIH and USASpending to identify grants awarded by the
NSF and USDA. NIH RePORTER is an online database of NIH-
funded research projects since 1992, and USASpending is an on-
line database of federally funded research grants since 2000.
Both databases contain information on each grant, including its
project title and funding amount. We stratiﬁed the grants by
year and recorded the number of projects and funding amounts
(in 2016 US dollars) by vitamin type, which we determined by
searching the project titles.
A study limitation is that we did not categorize identiﬁed re-
search grants with regard to study type. In other words, we did
not diﬀerentiate between grants in terms of their purpose (e.g., ba-
sic science, clinical trials, or meta-analysis). A second limitation is
that we counted multiyear grants only in the year of the grant’s
origination and we did not divide the value of the grant across
the grant’s study period.
Search strategy
On 15May 2016, we searched all project titles before 2016 to identify
all vitamin A, B, C, D, E, and K grants with the use of the search
terms shown in Table 1. We diﬀerentiated B-vitamins by those
forms that contained one-carbon from those that did not, as de-
scribed in Table 1.
Results
Federal research funding, 1992–2015
The proportion of federal research grant funding allotted to vitamins
declined from 1992 to 2015 from ;0.6% to 0.2%. Total federal re-
search spending (in 2016 US dollars), as reported by the NIH,
NSF, and USDA, increased from ;$14 billion in 1992 to $45 billion
in 2015; over the same time period, federal research spending (in
2016USdollars) for vitamins increased from;$89million to$95million
TABLE 1 Search terms used to identify vitamin research grants
Vitamin Search terms
Vitamin A vitamin a; carotene (all forms); carotenoids;
isotretinoin; palmitate; retinal; retinoic acid;
retinoid; retinol; retinyl acetate; retinyl
palmitate; cryptoxanthin; lycopene; lutein;
zeazanthin
Vitamin B (one-
carbon forms)
adermin; antipernicious anemia; cobalamin;
cyanocobalamin; folacin; folate; folic acid;
folinic acid; hydroxocobalamin; lactoﬂavin;
methylcobalamin; pteroyl-l-glutamate;
pteroyl-l-glutamic acid; pyridoxal;
pyridoxamine; pyridoxin; riboﬂavin; vitamin
b2; vitamin b6; vitamin b9; vitamin b12
Vitamin B (non–one-
carbon forms)
adenine; aneurin; antiberiberi factor; biotin;
choline; coenzyme r; niacin; nicotinamide;
nicotinic acid; pantothenate; pantothenic
acid; thiamin; vitamin b1; vitamin b3; vitamin
b4; vitamin b5; vitamin h
Vitamin C vitamin c; ascorbate; ascorbic acid
Vitamin D vitamin d; alfacalcidol; calcidiol; calcifediol;
calcitriol; cholecalciferol; dehydrocholesterol;
dihydroergocalciferol; ergocalciferol;
hydroxycholecalciferol
Vitamin E vitamin e; tocopherol; tocotrienol; vitamin e
acetate; vitamin e succinate
Vitamin K vitamin k; menadione; menaquinone;
phylloquinone; phytomenadione;
phytonadione
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(Figure 1). Budget sequestration required the NIH to cut 5% from its
2013 budget. Thus, the total research dollars awarded in 2015 more
closely resembled those awarded before the 2009 American Re-
covery and Reinvestment Act that aimed to stimulate economic
growth after the Great Recession (6).
Research funding by vitamin type
In our analysis of funding by vitamin type, we limited the data set to
the years 2000–2015 because reliable NSF and USDA funding data
are unavailable before 2000. From 2000 to 2015, federal agencies
awarded 1,732,197 research grants, of which 6035 (0.35%) pertained
to vitamins. We found notable variations in the number and value of
grants awarded by vitamin type (Table 2). Vitamin A was associated
with, on average, the most research projects per year (n = 115); vita-
min K was associated with the fewest (n = 8). Vitamin D projects
were associated with the greatest average yearly project value
($34.8 million); vitamin K projects were associated with the lowest
average yearly project value ($2.4 million).
The diﬀerences in funding trends by vitamin type were striking
(Figure 2). Funding, as a percentage of the 2000 level, increased for
only 2 vitamins—vitamin D and vitamin B (with the exception of
one-carbon B-vitamins)—over the studied time period. Vitamin D
funding peaked in 2013, at 326% of the federal funding awarded
for vitamin D research in 2000 (Supplemental Table 1). Although
funding for vitamin D research has since declined, its 2015 funding
was still 268% of its 2000 level. Vitamin B (with the exception of
one-carbon B-vitamins) peaked in 2006, at 269% of the 2000 bud-
get, before falling to 176% of the 2000 budget in 2015 (Supplemental
Table 1). In contrast to that for vitamin D and vitamin B (with the
exception of one-carbon B-vitamins), federal funding for each other
vitamin type was lower in 2015 than in 2000, with the greatest de-
clines in vitamin A and vitamin E (26% and 35% of 2000 funding
amounts, respectively). Funding for one-carbon B-vitamins was
42% of its 2000 level, but in absolute dollars was still 2-fold greater
than funding for forms of non–one-carbon B-vitamins.
Discussion
Our data from 1992 to 2015 show that there has been a dispropor-
tionate reduction in federal funding allocated for vitamin research
in the United States. Vitamin research has historically made signif-
icant contributions to the understanding of and improvement in
nutrition at the population level through its impact on dietary
guidance, vitamin fortiﬁcation, and vitamin supplementation (7). Vi-
tamin insuﬃciencies continue to be identiﬁed in national surveys
both in the United States (3, 8) and globally (9). Federally issued nu-
trition research agendas continue to identify vitamin research as
part of their roadmaps in the United States (4) and globally (10).
Therefore, it is critical to address the impact of the consistent de-
cline in federal funding for vitamin research relative to the potential
beneﬁts of sustained activity in this scientiﬁc discipline. First, we de-
scribe the impact of past federal funding for vitamins. We then dis-
cuss potential reasons for the overall decline in federal funding of
vitamin research and ﬁnally address the consequences of continued
reduction in funding.
FIGURE 1 All federal research funding compared with vitamin federal funding (in 2016 US dollars) from 1992 to 2015 as a percentage of
1992 levels. NIH, NSF, and USDA federal funding data are shown (NSF and USDA funding data were unavailable for the years before 2000);
NIH funding accounts for 96% of all funding after 2000. NSF, National Science Foundation.
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Vitamin research breakthroughs
Vitamin research has had an enormous and positive impact on global
population health (11). Vitamin research has allowed us to all but
eradicate basic nutrition-related diseases as a direct result of vitamin
deﬁciency—such as scurvy (vitamin C) (12), rickets (vitamin D) (13),
pellagra (nicotinic acid) (14), xerophthalmia (vitamin A) (15), and
beriberi (thiamine) (3) to name but a few—primarily through the
addition of micronutrients to food or direct supplementation of mal-
nourished populations. More recently, the discovery that con-
sumption of the recommended amount of folate before and during
early pregnancy can reduce the likelihood of neural tube defects
led to the implementation of a federally mandated folic acid forti-
ﬁcation program in the United States, which reduced the inci-
dence of neural tube defects in newborns by almost 20% (16)
and which has since been undertaken in nearly 80 other countries.
Beyond fortiﬁcation, many vitamins are integral to the treat-
ment of disease (17, 18), and the study of the biological properties
of vitamins has led to the development of a number of pharmaceu-
ticals. For instance, the study of vitamin K and its role in blood
clotting led to the vitamin K antagonists [e.g., Coumadin (warfa-
rin), Bristol-Myers Squibb] (19) that prevent clotting in patients
with coagulation disorders. The study of the impact of folate on
cell metabolism led to the ﬁrst antibiotics (sulfa drugs) as well
as the development of several chemotherapeutic agents that
FIGURE 2 Vitamin funding as a percentage of the 2000 funding level.
TABLE 2 Number and total grant awards by vitamin type1
Annual number
of projects
(2000–2015)
Total project value by award
(2000–2015), $ (3100,000)
Vitamin A 115 6 51 326 6 130
Vitamin B (one-
carbon)
74 6 26 218 6 51
Vitamin B (others) 27 6 6 64 6 19
Vitamin C 14 6 5 37 6 9
Vitamin D 101 6 33 348 6 160
Vitamin E 25 6 12 96 6 34
Vitamin K 8 6 2 24 6 6
1Values are means 6 SDs.
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remain important components of the current cancer treatment ar-
mamentarium (20, 21). Research continues to evaluate the role of
folate in cancer, including whether upregulation of folate receptors
on cancer cells can be used to target (22, 23) and locate (24) cancer
cells in patients. There remains an unresolved controversy that con-
tinues to aﬀect national nutrition policies worldwide as to whether
adequate dietary folate consumption protects against common can-
cers, at what doses, and whether the excessive amounts consumed
bymany in the form of supplements can paradoxically enhance can-
cer risk (25–27).
There has been considerable recent progress in vitamin D re-
search that coincides with a 300% increase in federal funding of
vitamin D over the past decade. Current studies are examining the
role of vitamin D on muscular function (28) and on left ventricular
structure and function (29), and on reducing the conversion of
prediabetic patients to diabetic patients (30). The optimal serum
concentration of 25-hydroxyvitamin D, which is an accepted bio-
marker of vitamin D, is being studied along with the association of
vitamin D deﬁciency with higher rates of hypertension (31–33),
high LDL cholesterol (34), and reduced innate immune system
function (35, 36) and executive cognitive function (37). Vitamin
D is a useful case study given that there has been a surge of funding
for this vitamin when funding for other vitamins is losing ground.
Although beyond the scope of our analysis, it would be particularly
useful to determine if the availability of a validated biomarker
for vitamin D created the need for more federal funding or if the in-
creased availability of funds for vitamin D research has driven more
discovery.
Potential reasons for the decline in research funding
Vitamins were discovered more than a century ago (4), and in this
era of rapid technological advancement and discovery, some may
consider the inﬂuence of new vitamin research to be diminishing
given the assumption that all of the vitamins have been discovered.
Another possible contributing factor to the steady decline in federal
vitamin funding is the growing uncertainty with regard to the health
beneﬁts of routine multivitamin supplementation in the general
population (38). The eﬀect of single-nutrient supplements on health
outcomes has not always been beneﬁcial (39), and there are incon-
sistent ﬁndings with regard to the role of vitamin supplements on
reduction in the risk of chronic diseases, such as cardiovascular dis-
ease (CVD) and cancer (10). Deﬁned as part of the Dietary Supple-
ment Health and Education Act, a dietary supplement is intended to
supplement the diet (40). Of concern is that;35% of US adults con-
sume dietary supplements on a regular basis (41) and that the seg-
ment of the population most likely to take dietary supplements
already has a healthy diet—hence, are at risk of an excessive intake
of single vitamins (42). For example, several groups have indepen-
dently raised concerns, on the basis of clinical observations, that el-
evated concentrations of blood folate within commonly accepted
ranges of normality place elderly individuals at a higher risk of the
clinical manifestations of vitamin B-12 deﬁciency; similarly (43–
45), there are concerns that excessive folate intake during pregnancy
in the setting of marginal vitamin B-12 status may be transmitting a
substantial risk of obesity and insulin resistance to oﬀspring (46). Al-
ternatively, there are those who express concern that individuals
who do not consume a healthy diet will rely on dietary supplements
to meet their nutritional needs (47). Although the study of routine
vitamin supplementation is only a small part of vitamin research
as awhole, the uncertainty surrounding itmay have had a dispropor-
tionate inﬂuence on funders and led to hesitation in funding broader
vitamin research.
However, the potential diminishing returns of further research
and uncertainty surrounding multivitamins may actually necessi-
tate more research. In contrast to the assumption of the diminish-
ing returns of vitamin research, there are growing concerns that
an appreciable number of North Americans do not meet the rec-
ommended intakes as suggested by the Institute of Medicine
and that subgroups of the US adult population have increased
needs for some vitamins, including but not limited to obese indi-
viduals, certain races/ethnicities, and older adults (5). There is
also evidence that individuals of low socioeconomic status have
not beneﬁted from an overall improvement in dietary patterns ob-
served among more aﬄuent segments of the US adult population
(48). However, the economic impact of inadequate vitamin status,
be it due to increased needs and/or poor eating habits, has been
poorly studied, with the exception of vitamin D (49).
With regard to questions surrounding vitamin supplementa-
tion, those conducting vitamin research in the community need
to consider high supplement doses with the use of principles of
drug regulation and respect the rule of “ﬁrst, do no harm” (50)
in their research. More importantly, vitamin research needs to
ﬁnd solutions through food and/or through combinations of vita-
mins as part of a healthy diet consistent with the Dietary Guide-
lines for Americans (5), and not in lieu of them.
Consequences of the current trend in vitamin funding and
potential solutions
Despite great contributions from vitamin research, funding to sup-
port the ﬁeld has persistently declined over recent decades. The
shortfall in funding will undoubtedly aﬀect our ability to leverage
new technologies and study designs emerging for other areas of
biomedical research as they applies to vitamin research. The impact
that insuﬃcient and inconsistent funding for vitamin research will
have on the career development of young investigators pursuing re-
search in this area will further delay research advances.
What is required is a fundamental change in our approaches to
vitamin research, which, in turn, requires a more innovative and
progressive perspective from federal funding agencies. Although
traditionally study has focused on “parent vitamins,” the science
has evolved to the examination of the role of metabolites and bio-
markers in health and disease. For example, niacin (51) and nico-
tinamide riboside have emerging roles in aging and survival,
whereas the role of thiamine supplementation on heart failure re-
duction is also being studied (52). There is great potential for this
research to be applied to tailor care to individual patients and pre-
vention to high-risk groups (e.g., the elderly, cancer survivors,
groups with metabolic disorders, or those suﬀering from particu-
lar diseases), consistent with current funding priorities for person-
alized medicine and prevention strategies (1). However, further
advancements in conventional randomized clinical trial designs
may be needed, because when testing the eﬀects of speciﬁed
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vitamin intake amounts, which are virtually always superimposed
on extant intakes, there is no true placebo (53, 54) and perhaps
depletion and repletion studies may be more appropriate to develop
personalized nutrition protocols. We may also need to consider
other preclinical models for the study of vitamins in the prevention
of chronic disease, including the development of appropriate human
in vitro model systems, including organoids, to minimize the use of
animals, with reproducibility demonstrated in human trials.
This evolution in how we approach vitamin research in many
ways mirrors the evolution of the science in other areas. In partic-
ular, pharmaceutical research has moved away from the focus of
treating populations to a focus on individuals, with new treat-
ments tailored to patients’ individual characteristics. The advent
of precision medicine (1) also provides an opportunity for re-
searchers to advance our understanding of the relation between
genetics, vitamins, and pharmaceuticals; and there are already a
number of emerging and encouraging data showing the modiﬁca-
tion of the metabolic eﬀect of vitamins by genotype. Individuals
carrying the 5,10-methylenetetrahydrofolate reductase (MTHFR)
677TT polymorphism, which is reported to be found in some pop-
ulations, have a #32% higher risk of CVD and hypertension. A
number of recent randomized controlled trials (RCTs) showed that
riboﬂavin supplementation can signiﬁcantly reduce systolic blood
pressure by 5–13 mm Hg in these genetically at-risk adults (55).
There is a need to better understand the relation between vita-
min requirements and eating patterns and human metabolic
processes, particularly when choosing between low- and high-
macronutrient (fat, protein, carbohydrate) diets. Even worse, if
we do ignore progress in this ﬁeld we might even draw the wrong
conclusions. After encouraging data associating a lower risk of
CVD with adequate vitamin E intake, a number of large-scale
RCTs were initiated to investigate this ﬁnding. It was with sur-
prise to many that the majority of the RCTs reported a null eﬀect
of vitamin E on CVD; however, they did not take genotype into ac-
count. In diabetic patients who carry the haptoglobin 2-2 geno-
type, which has inferior antioxidant properties, 400 mg vitamin
E signiﬁcantly reduced the 18-mo risk of cardiovascular events
(56) and this eﬀect was also shown for diabetic patients in the
HOPE trial when genotype was taken into account (57). These ex-
amples show the importance of providing funds to investigate the
role of vitamins applying current knowledge. An understanding of
the contribution of proteins, genes, and metabolites to individual
variation may facilitate the expansion from public health die-
tary guidelines to more evidence-based dietary guidance that
is tailored to the individual and that accounts for eating patterns,
disease status, disease risk, genetic proﬁle, and patient behavior,
particularly for those in speciﬁc risk groups. In this way, there is
promise in leveraging “big data” analytics—the integration of large
and diverse data sets toward answering wide-ranging research
questions—to advance nutritional sciences and to develop and
test predictive mathematical models of the eﬀects of vitamin sup-
plementation in diﬀerent genetic, epigenetic, and macronutrient
backgrounds. As reviewed elsewhere (58), the use of modeling for
standardization of data and data interpretation, to ﬁll in geograph-
ical gaps in the knowledge and for integrating multiple variables,
is critical for moving nutrition research forward. Such research
innovations have the potential to ﬁnd clinically meaningful relations
between individual variations, disease, and nutrition and vitamin
consumption that can be tested to positively aﬀect patient health.
The National Nutrition Research Roadmap 2016–2021 calls for
support of collaborative, interdisciplinary research for under-
standing the short- and long-term eﬀects of dietary and physical
activity patterns on health across the life stages (4). If vitamin re-
search is to fulﬁll its promise, a similar collaborative approach is
required. Furthermore, to fully address research gaps and oppor-
tunities, better coordination between the federal funding agencies,
academic researchers, and training programs is needed.
Conclusions
The study of vitamins has been fundamental to advancements in nu-
trition, medicine, and global public health. Current research holds
promise for further progress in our understanding and treatment
of a variety of diseases and high-risk subgroups. If we are to reap
the beneﬁts of this new frontier of vitamin research, it is vital for
funding streams to keep pace with the evolving science andmaintain
relevance to the emerging needs of achieving optimal health and re-
ducing morbidity in aging populations.
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